The combination of these factors may be highly significant for predicting and classifying aggressive PDAC with higher malignant potential before initiating treatment.
← all excerpts
Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma.
1
—
—